Kymera Therapeutics, Inc. — SC 13G Filings
10 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Kymera Therapeutics, Inc. (KYMR), sorted by most recent first. Each row links to the full filing on EdgarLookup. Kymera Therapeutics, Inc. has filed 10 SC 13G documents with the SEC since 2020. To view all SEC filings by Kymera Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | — | 0000315066-24-002814 | Nov 12, 2024 | — |
| SC 13G | SC 13G | 0001104659-23-021478 | Feb 14, 2023 | — |
| SC 13G | KYMERA THERAPEUTICS, INC. | 0000902664-23-001682 | Feb 14, 2023 | — |
| SC 13G | — | 0000080255-22-002240 | Feb 14, 2022 | — |
| SC 13G | SCHEDULE 13G | 0001104659-22-017929 | Feb 10, 2022 | — |
| SC 13G | — | 0000834237-22-007308 | Feb 4, 2022 | — |
| SC 13G | SEC SCHEDULE 13G | 0001678858-22-000309 | Feb 4, 2022 | — |
| SC 13G | SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP | 0001839882-21-002168 | Feb 16, 2021 | — |
| SC 13G | SC 13G | 0001104659-21-023971 | Feb 16, 2021 | — |
| SC 13G | — | 0000315066-21-001105 | Feb 8, 2021 | — |